|
1
|
Maher TM, Wells AU and Laurent GJ:
Idiopathic pulmonary fibrosis: multiple causes and multiple
mechanisms? Eur Respir J. 30:835–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fernández Pérez ER, Daniels CE, Schroeder
DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES and Ryu JH:
Incidence, prevalence, and clinical course of idiopathic pulmonary
fibrosis: a population-based study. Chest. 137:129–137.
2010.PubMed/NCBI
|
|
3
|
Navaratnam V, Fleming KM, West J, Smith
CJ, Jenkins RG, Fogarty A and Hubbard RB: The rising incidence of
idiopathic pulmonary fibrosis in the U.K. Thorax. 66:462–467. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nalysnyk L, Cid-Ruzafa J, Rotella P and
Esser D: Incidence and prevalence of idiopathic pulmonary fibrosis:
review of the literature. Eur Respir Rev. 21:355–361. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ley B, Collard HR and King TE Jr: Clinical
course and prediction of survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 183:431–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yokoyama A, Kondo K, Nakajima M,
Matsushima T, Takahashi T, Nishimura M, Bando M, Sugiyama Y, Totani
Y, Ishizaki T, Ichiyasu H, Suga M, Hamada H and Kohno N: Prognostic
value of circulating KL-6 in idiopathic pulmonary fibrosis.
Respirology. 11:164–168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prasse A, Probst C, Bargagli E, Zissel G,
Toews GB, Flaherty KR, Olschewski M, Rottoli P and Muller-Quernheim
J: Serum CC-chemokine ligand 18 concentration predicts outcome in
idiopathic pulmonary fibrosis. Am J Respir Crit Care Med.
179:717–723. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kinder BW, Brown KK, McCormack FX, Ix JH,
Kervitsky A, Schwarz MI and King TE Jr: Serum surfactant protein-A
is a strong predictor of early mortality in idiopathic pulmonary
fibrosis. Chest. 135:1557–1563. 2009. View Article : Google Scholar
|
|
9
|
Rosas IO, Richards TJ, Konishi K, Zhang Y,
Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo
A, Sciurba F, Dauber J, Selman M, Gochuico BR and Kaminski N: MMP1
and MMP7 as potential peripheral blood biomarkers in idiopathic
pulmonary fibrosis. PLoS Med. 5:e932008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin KY, Zhang XJ, Feng DD, Zhang H, Zeng
CW, Han BW, Zhou AD, Qu LH, Xu L and Chen YQ: miR-125b, a target of
CDX2, regulates cell differentiation through repression of the core
binding factor in hematopoietic malignancies. J Biol Chem.
286:38253–38263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han BW, Feng DD, Li ZG, Luo XQ, Zhang H,
Li XJ, Zhang XJ, Zheng LL, Zeng CW, Lin KY, Zhang P, Xu L and Chen
YQ: A set of miRNAs that involve in the pathways of drug resistance
and leukemic stem-cell differentiation is associated with the risk
of relapse and glucocorticoid response in childhood ALL. Hum Mol
Genet. 20:4903–4915. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hwang MS, Yu N, Stinson SY, Yue P, Newman
RJ, Allan BB and Dornan D: miR-221/222 targets adiponectin receptor
1 to promote the epithelial-to-mesenchymal transition in breast
cancer. PLoS One. 8:e665022013. View Article : Google Scholar
|
|
13
|
Paterson EL, Kazenwadel J, Bert AG,
Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of
the miRNA-200 family at the invasive front of colorectal cancers
with degraded basement membrane indicates EMT is involved in cancer
progression. Neoplasia. 15:180–191. 2013.PubMed/NCBI
|
|
14
|
Cheng CW, Wang HW, Chang CW, Chu HW, Chen
CY, Yu JC, Chao JI, Liu HF, Ding SL and Shen CY: MicroRNA-30a
inhibits cell migration and invasion by downregulating vimentin
expression and is a potential prognostic marker in breast cancer.
Breast Cancer Res Treat. 134:1081–1093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bala S, Tilahun Y, Taha O, Alao H, Kodys
K, Catalano D and Szabo G: Increased microRNA-155 expression in the
serum and peripheral monocytes in chronic HCV infection. J Transl
Med. 10:1512012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van der Meer AJ, Farid WR, Sonneveld MJ,
de Ruiter PE, Boonstra A, van Vuuren AJ, Verheij J, Hansen BE, de
Knegt RJ, van der Laan LJ and Janssen HL: Sensitive detection of
hepatocellular injury in chronic hepatitis C patients with
circulating hepatocyte-derived microRNA-122. J Viral Hepat.
20:158–166. 2013.PubMed/NCBI
|
|
17
|
Haghikia A, Haghikia A, Hellwig K,
Baraniskin A, Holzmann A, Décard BF, Thum T and Gold R: Regulated
microRNAs in the CSF of patients with multiple sclerosis: a
case-control study. Neurology. 79:2166–2170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mitchell PS1, Parkin RK, Kroh EM, Fritz
BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J,
O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS,
Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB and
Tewari M: Circulating microRNAs as stable blood-based markers for
cancer detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu R, Chen X, Du Y, Yao W, Shen L, Wang
C, Hu Z, Zhuang R, Ning G, Zhang C, Yuan Y, Li Z, Zen K, Ba Y and
Zhang CY: Serum microRNA expression profile as a biomarker in the
diagnosis and prognosis of pancreatic cancer. Clin Chem.
58:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang C, Wang C, Chen X, Chen S, Zhang Y,
Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY
and Zhang C: Identification of seven serum microRNAs from a
genome-wide serum microRNA expression profile as potential
noninvasive biomarkers for malignant astrocytomas. Int J Cancer.
132:116–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li P, Zhao GQ, Chen TF, Chang JX, Wang HQ,
Chen SS and Zhang GJ: Serum miR-21 and miR-155 expression in
idiopathic pulmonary fibrosis. J Asthma. 50:960–964. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raghu G, Collard HR, Egan JJ, et al: An
official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis:
evidence-based guidelines for diagnosis and management. Am J Respir
Crit Care Med. 183:788–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lawrie CH, Gal S, Dunlop HM, Pushkaran B,
Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J,
Wainscoat JS, Hatton CS and Harris AL: Detection of elevated levels
of tumour-associated microRNAs in serum of patients with diffuse
large B-cell lymphoma. Br J Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng H, Zhang L, Zhao Y, Yang D, Song F,
Wen Y, Hao Q, Hu Z, Zhang W and Chen K: Plasma miRNAs as diagnostic
and prognostic biomarkers for ovarian cancer. PLoS One.
8:e778532013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ,
Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum
miR-21 and tumor miR-200c associated with poor prognosis in
patients with lung cancer. Med Oncol. 29:618–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Gu J, Roth JA, Hildebrandt MA,
Lippman SM, Ye Y, Minna JD and Wu X: Pathway-based serum microRNA
profiling and survival in patients with advanced stage non-small
cell lung cancer. Cancer Res. 73:4801–4809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang
L, Huang D, Tan C, Sheng W and Du X: Plasma miR-601 and miR-760 are
novel biomarkers for the early detection of colorectal cancer. PLoS
One. 7:e443982012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Laterza OF, Lim L, Garrett-Engele PW,
Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL,
Sistare FD and Glaab WE: Plasma MicroRNAs as sensitive and specific
biomarkers of tissue injury. Clin Chem. 55:1977–1983. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tryndyak VP, Latendresse JR, Montgomery B,
Ross SA, Beland FA, Rusyn I and Pogribny IP: Plasma microRNAs are
sensitive indicators of inter-strain differences in the severity of
liver injury induced in mice by a choline- and folate-deficient
diet. Toxicol Appl Pharmacol. 262:52–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu G, Friggeri A, Yang Y, Milosevic J,
Ding Q, Thannickal VJ, Kaminski N and Abraham E: miR-21 mediates
fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J
Exp Med. 207:1589–1597. 2010. View Article : Google Scholar : PubMed/NCBI
|
